Clinical Trial Update: Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating escalating doses of dimiracetam in AIDS patients with painful neuropathy showed safety and preliminary evidence of efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• Peripheral Neuropathy

Drugs mentioned

• Dimiracetam (dimiracetam)

Snippet

Sponsor: Neurotune AG | Conditions: Neuropathy, AIDS | Phase 2 | Status: COMPLETED